Henry Schein (HSIC) Competitors

$74.37 +2.35 (+3.26%)

Closing price 04:00 PM Eastern

Extended Trading

$75.74 +1.36 (+1.84%)

As of 07:00 PM Eastern

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

Should you be buying Henry Schein stock or one of its competitors? The main competitors of Henry Schein include Cooper Companies (COO), IDEXX Laboratories (IDXX), Masimo (MASI), Merit Medical Systems (MMSI), and AMN Healthcare Services (AMN). These companies are all part of the "medical" sector.

How does Henry Schein compare to Cooper Companies?

Henry Schein (NASDAQ:HSIC) and Cooper Companies (NASDAQ:COO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

: Cooper Companies has a net margin of 9.67% compared to Henry Schein's net margin of 3.02%. Henry Schein's return on equity of 15.16% beat Cooper Companies' return on equity.
Company Net Margins Return on Equity Return on Assets
Henry Schein 3.02% 15.16% 5.54%
Cooper Companies 9.67% 10.34% 6.93%
: Henry Schein presently has a consensus target price of $87.75, indicating a potential upside of 17.99%. Cooper Companies has a consensus target price of $90.79, indicating a potential upside of 48.22%. Given Cooper Companies' stronger consensus rating and higher possible upside, analysts plainly believe Cooper Companies is more favorable than Henry Schein.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
1 Sell rating(s)
7 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.36
Cooper Companies
1 Sell rating(s)

7 Hold rating(s)

8 Buy rating(s)

1 Strong Buy rating(s)
2.53
: 96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: Henry Schein has higher revenue and earnings than Cooper Companies. Henry Schein is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Henry Schein $13.18B 0.65 $398M $3.27 22.74
Cooper Companies $4.15B 2.88 $374.90M $2.02 30.32
: In the previous week, Henry Schein had 8 more articles in the media than Cooper Companies. MarketBeat recorded 20 mentions for Henry Schein and 12 mentions for Cooper Companies. Henry Schein's average media sentiment score of 0.46 beat Cooper Companies' score of 0.28 indicating that Henry Schein is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Henry Schein
5 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cooper Companies
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
4 Very Negative mention(s)
Neutral
: Henry Schein has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	3.02%	15.16%	5.54%
Cooper Companies	9.67%	10.34%	6.93%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Cooper Companies	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.65	$398M	$3.27	22.74
Cooper Companies	$4.15B	2.88	$374.90M	$2.02	30.32

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cooper Companies	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	4 Very Negative mention(s)	Neutral

Summary

Cooper Companies beats Henry Schein on 10 of the 17 factors compared between the two stocks.

How does Henry Schein compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

: IDEXX Laboratories has a net margin of 24.62% compared to Henry Schein's net margin of 3.02%. IDEXX Laboratories' return on equity of 69.78% beat Henry Schein's return on equity.
Company Net Margins Return on Equity Return on Assets
IDEXX Laboratories 24.62% 69.78% 31.91%
Henry Schein 3.02% 15.16% 5.54%
: IDEXX Laboratories currently has a consensus target price of $751.00, suggesting a potential upside of 33.40%. Henry Schein has a consensus target price of $87.75, suggesting a potential upside of 17.99%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe IDEXX Laboratories is more favorable than Henry Schein.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IDEXX Laboratories
0 Sell rating(s)
4 Hold rating(s)

7 Buy rating(s)

0 Strong Buy rating(s)
2.64
Henry Schein
1 Sell rating(s)

7 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.36
: 87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by company insiders. Comparatively, 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: IDEXX Laboratories has higher earnings, but lower revenue than Henry Schein. Henry Schein is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IDEXX Laboratories $4.30B 10.39 $1.06B $13.07 43.07
Henry Schein $13.18B 0.65 $398M $3.27 22.74
: In the previous week, IDEXX Laboratories had 5 more articles in the media than Henry Schein. MarketBeat recorded 25 mentions for IDEXX Laboratories and 20 mentions for Henry Schein. IDEXX Laboratories' average media sentiment score of 1.08 beat Henry Schein's score of 0.46 indicating that IDEXX Laboratories is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IDEXX Laboratories
12 Very Positive mention(s)
2 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Henry Schein
5 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: IDEXX Laboratories has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	24.62%	69.78%	31.91%
Henry Schein	3.02%	15.16%	5.54%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.64
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.39	$1.06B	$13.07	43.07
Henry Schein	$13.18B	0.65	$398M	$3.27	22.74

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	12 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

IDEXX Laboratories beats Henry Schein on 13 of the 16 factors compared between the two stocks.

How does Henry Schein compare to Masimo?

Masimo (NASDAQ:MASI) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

: Masimo has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.
: 86.0% of Masimo shares are held by institutional investors. Comparatively, 96.6% of Henry Schein shares are held by institutional investors. 16.9% of Masimo shares are held by company insiders. Comparatively, 0.9% of Henry Schein shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: Henry Schein has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Masimo $1.53B 6.28 -$151.50M -$10.54 N/A
Henry Schein $13.18B 0.65 $398M $3.27 22.74
: Henry Schein has a net margin of 3.02% compared to Masimo's net margin of -9.92%. Masimo's return on equity of 32.02% beat Henry Schein's return on equity.
Company Net Margins Return on Equity Return on Assets
Masimo -9.92% 32.02% 13.73%
Henry Schein 3.02% 15.16% 5.54%
: Masimo currently has a consensus target price of $181.17, suggesting a potential upside of 1.45%. Henry Schein has a consensus target price of $87.75, suggesting a potential upside of 17.99%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts plainly believe Henry Schein is more favorable than Masimo.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Masimo
1 Sell rating(s)
8 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.89
Henry Schein
1 Sell rating(s)

7 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.36
: In the previous week, Henry Schein had 11 more articles in the media than Masimo. MarketBeat recorded 20 mentions for Henry Schein and 9 mentions for Masimo. Henry Schein's average media sentiment score of 0.46 beat Masimo's score of 0.39 indicating that Henry Schein is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Masimo
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Henry Schein
5 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Masimo	$1.53B	6.28	-$151.50M	-$10.54	N/A
Henry Schein	$13.18B	0.65	$398M	$3.27	22.74

Company	Net Margins	Return on Equity	Return on Assets
Masimo	-9.92%	32.02%	13.73%
Henry Schein	3.02%	15.16%	5.54%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Masimo	1 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.89
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Masimo	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Henry Schein	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Henry Schein beats Masimo on 11 of the 16 factors compared between the two stocks.

How does Henry Schein compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Henry Schein (NASDAQ:HSIC) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

: Merit Medical Systems has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Henry Schein has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.
: 99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: Henry Schein has higher revenue and earnings than Merit Medical Systems. Henry Schein is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Merit Medical Systems $1.54B 2.34 $128.49M $2.31 26.16
Henry Schein $13.18B 0.65 $398M $3.27 22.74
: Merit Medical Systems has a net margin of 9.03% compared to Henry Schein's net margin of 3.02%. Henry Schein's return on equity of 15.16% beat Merit Medical Systems' return on equity.
Company Net Margins Return on Equity Return on Assets
Merit Medical Systems 9.03% 13.54% 7.94%
Henry Schein 3.02% 15.16% 5.54%
: Merit Medical Systems presently has a consensus target price of $92.80, indicating a potential upside of 53.54%. Henry Schein has a consensus target price of $87.75, indicating a potential upside of 17.99%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, equities research analysts plainly believe Merit Medical Systems is more favorable than Henry Schein.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
3 Hold rating(s)

8 Buy rating(s)

0 Strong Buy rating(s)
2.73
Henry Schein
1 Sell rating(s)

7 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.36
: In the previous week, Merit Medical Systems had 17 more articles in the media than Henry Schein. MarketBeat recorded 37 mentions for Merit Medical Systems and 20 mentions for Henry Schein. Merit Medical Systems' average media sentiment score of 0.72 beat Henry Schein's score of 0.46 indicating that Merit Medical Systems is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
14 Very Positive mention(s)
6 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Henry Schein
5 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.54B	2.34	$128.49M	$2.31	26.16
Henry Schein	$13.18B	0.65	$398M	$3.27	22.74

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
Henry Schein	3.02%	15.16%	5.54%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	14 Very Positive mention(s)	6 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Merit Medical Systems beats Henry Schein on 10 of the 16 factors compared between the two stocks.

How does Henry Schein compare to AMN Healthcare Services?

Henry Schein (NASDAQ:HSIC) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

: Henry Schein has a net margin of 3.02% compared to AMN Healthcare Services' net margin of -3.51%. Henry Schein's return on equity of 15.16% beat AMN Healthcare Services' return on equity.
Company Net Margins Return on Equity Return on Assets
Henry Schein 3.02% 15.16% 5.54%
AMN Healthcare Services -3.51% 8.05% 2.38%
: In the previous week, Henry Schein had 13 more articles in the media than AMN Healthcare Services. MarketBeat recorded 20 mentions for Henry Schein and 7 mentions for AMN Healthcare Services. Henry Schein's average media sentiment score of 0.46 beat AMN Healthcare Services' score of 0.37 indicating that Henry Schein is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Henry Schein
5 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AMN Healthcare Services
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Henry Schein presently has a consensus target price of $87.75, indicating a potential upside of 17.99%. AMN Healthcare Services has a consensus target price of $22.64, indicating a potential upside of 6.41%. Given Henry Schein's higher possible upside, analysts plainly believe Henry Schein is more favorable than AMN Healthcare Services.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
1 Sell rating(s)
7 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
2.36
AMN Healthcare Services
2 Sell rating(s)

2 Hold rating(s)

4 Buy rating(s)

1 Strong Buy rating(s)
2.44
: 96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
: Henry Schein has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Henry Schein $13.18B 0.65 $398M $3.27 22.74
AMN Healthcare Services $2.73B 0.30 -$95.70M -$2.49 N/A
: Henry Schein has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	3.02%	15.16%	5.54%
AMN Healthcare Services	-3.51%	8.05%	2.38%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Henry Schein	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AMN Healthcare Services	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
AMN Healthcare Services	2 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.44

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.65	$398M	$3.27	22.74
AMN Healthcare Services	$2.73B	0.30	-$95.70M	-$2.49	N/A

Summary

Henry Schein beats AMN Healthcare Services on 13 of the 17 factors compared between the two stocks.

Get Henry Schein News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSIC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSIC vs. The Competition

Export

Metric	Henry Schein	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$8.53B	$14.79B	$6.25B	$11.87B
Dividend Yield	N/A	2.01%	2.73%	5.21%
P/E Ratio	22.74	15.94	29.04	28.48
Price / Sales	0.65	2.00	476.48	60.89
Price / Cash	9.50	12.79	27.62	36.52
Price / Book	2.25	3.00	9.67	6.67
Net Income	$398M	$452.74M	$3.55B	$332.64M
7 Day Performance	-2.30%	-0.62%	1.70%	2.01%
1 Month Performance	0.58%	4.26%	5.62%	9.19%
1 Year Performance	11.70%	-2.44%	34.42%	39.59%

Henry Schein Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSIC Henry Schein	3.5892 of 5 stars	$74.37 +3.3%	$87.75 +18.0%	N/A	$8.53B	$13.18B	22.74	25,000	Trending News Earnings Report
COO Cooper Companies	3.4287 of 5 stars	$64.34 -0.1%	$90.79 +41.1%	N/A	$12.57B	$4.09B	31.85	15,000
IDXX IDEXX Laboratories	4.0185 of 5 stars	$574.95 +1.6%	$760.00 +32.2%	N/A	$44.95B	$4.30B	43.99	11,000	Trending News Earnings Report
MASI Masimo	1.261 of 5 stars	$178.66 +0.0%	$181.17 +1.4%	N/A	$9.59B	$1.53B	N/A	2,200	News Coverage
MMSI Merit Medical Systems	4.4452 of 5 stars	$67.43 -1.7%	$99.56 +47.6%	N/A	$4.09B	$1.52B	31.81	7,500	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSIC) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

How does Henry Schein compare to Cooper Companies?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Summary

How does Henry Schein compare to Masimo?

Summary

How does Henry Schein compare to Merit Medical Systems?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Henry Schein (HSIC) Competitors

HSIC vs. COO, IDXX, MASI, MMSI, and AMN

How does Henry Schein compare to Cooper Companies?

Summary

How does Henry Schein compare to IDEXX Laboratories?

Summary

How does Henry Schein compare to Masimo?

Summary

How does Henry Schein compare to Merit Medical Systems?

Summary

How does Henry Schein compare to AMN Healthcare Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSIC vs. The Competition

Henry Schein Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools